Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

The Social Capital Hedosophia VI SPAC Could Be Profitable for Investors

At a time when its hard to find equities that aren't speculative, IPOF stock looks like a reasonable, worthwhile investment.

8 Electric Vehicle Stocks With Long-Term Stories

Electric vehicle stocks carry speculative risk. However the projected growth for electric vehicles gives these stocks strong long-term stories.

Should You Like Facebook Stock If the Company Doesn’t Like You Back?

As society starts asking the right questions about the trade-offs of social media to our privacy, it’s worth asking how much you should like Facebook stock.

Romeo PowerIs Well-Positioned Enough to Be Worth a Look on This Dip

RMO stock is going public just as the bar is being raised on all EV stocks. Fortunately, the company has a story that should meet the moment.

Jaguar Health Has a Strong Outline, But the Story Is Unclear

The 12-month, 300% gain with JAGX stock has a lot of headline news. There’s a lot to like, but will Jaguar be able to build on its gains?